E.-C. Hirsch - JoVE Visualize

Showing results (61-70 of 141) with videos related to

Pageof 15

Sort By:

Neuroscience|January 1, 1991

Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.

Neuroscience|January 1, 1990

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization studyF Javoy-Agid, E C Hirsch, S Dumas, et al.

Neuroscience Letters|October 27, 1995

Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's diseaseR Levy, M Vila, M T Herrero, et al.

Neuroscience Letters|November 21, 1994

Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's diseaseJ Villares, O Strada, B Faucheux, et al.

Neuroscience Letters|May 19, 1994

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseG Boka, P Anglade, D Wallach, et al.

Brain Research|October 8, 1993

Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentumM T Herrero, E C Hirsch, F Javoy-Agid, et al.

Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994

High affinity neurotrophin receptors in cholinergic neurons in the human brainF Boissière, S Hunot, B Faucheux, et al.

Journal of Neurochemistry|September 1, 1992

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?A Kastner, E C Hirsch, O Lejeune, et al.

Dementia and Geriatric Cognitive Disorders|January 1, 1997

Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's diseaseF Boissière, S Hunot, B Faucheux, et al.

Annals of the New York Academy of Sciences|July 9, 2003

The role of glial reaction and inflammation in Parkinson's diseaseE C Hirsch, T Breidert, E Rousselet, et al.

Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:

Pageof 15

Neuroscience|January 1, 1991

Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.

Neuroscience|January 1, 1990

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization studyF Javoy-Agid, E C Hirsch, S Dumas, et al.

Neuroscience Letters|October 27, 1995

Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's diseaseR Levy, M Vila, M T Herrero, et al.

Neuroscience Letters|November 21, 1994

Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's diseaseJ Villares, O Strada, B Faucheux, et al.

Neuroscience Letters|May 19, 1994

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseG Boka, P Anglade, D Wallach, et al.

Brain Research|October 8, 1993

Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentumM T Herrero, E C Hirsch, F Javoy-Agid, et al.

Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994

High affinity neurotrophin receptors in cholinergic neurons in the human brainF Boissière, S Hunot, B Faucheux, et al.

Journal of Neurochemistry|September 1, 1992

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?A Kastner, E C Hirsch, O Lejeune, et al.

Dementia and Geriatric Cognitive Disorders|January 1, 1997

Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's diseaseF Boissière, S Hunot, B Faucheux, et al.

Annals of the New York Academy of Sciences|July 9, 2003

The role of glial reaction and inflammation in Parkinson's diseaseE C Hirsch, T Breidert, E Rousselet, et al.

Pageof 15